Becton Dickinson and

200.40
0.00 (0.00%)
At close: Apr 17, 2025, 11:38 AM
0.00%
Bid 200.2
Market Cap 57.54B
Revenue (ttm) 20.64B
Net Income (ttm) 1.73B
EPS (ttm) 5.93
PE Ratio (ttm) 33.79
Forward PE 12.92
Analyst Buy
Ask 200.51
Volume 1,571,856
Avg. Volume (20D) 2,145,980
Open 199.50
Previous Close 200.40
Day's Range 198.73 - 200.84
52-Week Range 193.03 - 251.99
Beta 0.38

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and pr...

Sector Healthcare
IPO Date Feb 21, 1973
Employees 70,000
Stock Exchange NYSE
Ticker Symbol BDX
Full Company Profile

Analyst Forecast

According to 7 analyst ratings, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $275, which is an increase of 37.23% from the latest price.

Stock Forecasts

Next Earnings Release

Becton Dickinson and is scheduled to release its earnings on May 1, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-7.28%
Becton, Dickinson and Company shares are trading l... Unlock content with Pro Subscription
2 months ago
+1.09%
Becton, Dickinson and Company shares are trading lower following Q1 financial results.